Fatmeh Abbas

Fatmeh Abbas

Auto-generated profile, based on publicly available information

Fatmeh Abbas

Department of Pathology & Laboratory Medicine, AUBMC, Lebanon

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2020 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
CMChristopher A. Maroun
Christopher A. Maroun
KFKarine Al Feghali
Karine Al Feghali
HTHenri Traboulsi
Henri Traboulsi
HDHelene Dabbous
Helene Dabbous
FAFatmeh Abbas
Fatmeh Abbas
RMRoger V. Moukarbel
Roger V. Moukarbel
Background: Given the paucity of data and widely variable rates that have been reported, the main objective of this study was to examine the prevalence of HPV-positivity in oropharyngeal squamous cell carcinoma (OPSCC) in Middle Eastern patients presenting to one of the region’s largest tertiary care centers using polymerase chain reaction (PCR) amplification of the HPV E6/E7 oncogenes, a highly sensitive and specific method of detection.Methods: Medical charts and archived pathological specimens were obtained for patients diagnosed with biopsy proven oropharyngeal cancer who presented to the American University of Beirut Medical Center between 1972 and 2017. DNA was extracted from paraffin-embedded specimens and tested for 30 high-risk and low-risk papilloma viruses using the PCR-based EUROarray HPV kit (EuroImmun).Results: A total of 57 patients with oropharyngeal cancer were initially identified; only 34 met inclusion/exclusion criteria and were included in the present study. Most patients were males (73.5%) from Lebanon (79.4%). The most common primary tumor site was in the base of tongue (50%), followed by the tonsil (41.2%). The majority of patients (85.3%) tested positive for HPV DNA.Conclusion: The prevalence of HPV-positivity amongst Middle Eastern OPSCC patients, specifically those from Lebanon, may be far greater than previously thought. The Lebanese population and other neighboring Middle Eastern countries may require a more vigilant approach towards HPV detection and awareness. On an international level, further research is required to better elucidate non-classical mechanisms of HPV exposure and transmission.

4 January 2021 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
MSMaelle Saliba
Maelle Saliba
MSMuhammad Shaheen
Muhammad Shaheen
RHRana El Hajj
Rana El Hajj
FAFatmeh Abbas
Fatmeh Abbas
SBShaarif Bashir
Shaarif Bashir
IKIbrahim Khalifeh
Ibrahim Khalifeh

1 April 2016 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
BYBassem Yamout
Bassem Yamout
NKNathalie M. Karaky
Nathalie M. Karaky
RMRami A.R. Mahfouz
Rami A.R. Mahfouz
FJFadel Jaber
Fadel Jaber
NENour Estaitieh
Nour Estaitieh
RDRose T. Daher
Rose T. Daher

1 September 2012 in Gene
Verified
Journal Article
Closed access
SKSara Khansa
Sara Khansa
RHRouba Hoteit
Rouba Hoteit
DSDina Shammaa
Dina Shammaa
RKRabab Abdel Khalek
Rabab Abdel Khalek
HHHussein El Halas
Hussein El Halas
RMRami A.R. Mahfouz
Rami A.R. Mahfouz

1 January 2013 in Gene
Verified
Journal Article
Closed access
SKSara Khansa
Sara Khansa
RHRouba Hoteit
Rouba Hoteit
DSDina Shammaa
Dina Shammaa
RKRabab Abdel Khalek
Rabab Abdel Khalek
HHHussein El Halas
Hussein El Halas
RMRami A.R. Mahfouz
Rami A.R. Mahfouz

1 December 2014 in Genetic Testing and Molecular Biomarkers
Verified
Journal Article
Closed access
FAFatmeh Abbas
Fatmeh Abbas
SYSouha N. Yazbek
Souha N. Yazbek
DSDina Shammaa
Dina Shammaa
RHRouba Hoteit
Rouba Hoteit
PFPuzant Fermanian
Puzant Fermanian
RMRami Mahfouz
Rami Mahfouz
To determine the frequency of positive reactions obtained using the Invivoscribe BIOMED-2 kit for B-cell gene rearrangement studies in leukemias and lymphomas. We reviewed the gel patterns for 192 samples tested, using the above-mentioned kit and matched the positive signal with the corresponding mix available in the assay kit. 92.2% had immunoglobulin heavy-chain clonality, of which 74% were detected by the IgH VH-FR1+JH primer set, 75.5% by IgH VH-FR2+JH primer set, 65.1% by IgH VH-FR3+JH primer set, 26% by IgH DH+JH primer set, and 2.1% by IgH DH7+JH primer set. In addition, 55.7% had clonality in the kappa light chain, where 33.3% were positive by the IgK Vκ +Jκ primer set and 39.6% by IgK Vκ and INTR+Kde primer sets. Clonality in the lambda light chain of immunoglobulins was detected in 17.7% of specimens tested using the IgL Vλ +Jλ primer set. All primer mixes provided by the assay were positive. Thus, the Invivoscribe BIOMED-2 B-cell gene rearrangement kit is very reliable in adequately covering all targets represented by the master mixes. This assay is an integral part of the differential diagnosis of clonal populations of cells. Our report is the first in the literature that describes the full range of coverage of the BIOMED-2 primer mixes provided in this assay.